Viz.ai, the Proven AI-Powered Care Coordination Platform

Viz.ai is a medical AI company headquartered in San Francisco, California, founded in 2016 by Chris Mansi and David Golan. The company develops software that analyzes medical imaging data and automates care coordination workflows, with a focus on time-critical conditions including stroke, pulmonary embolism, aortic dissection, and cardiac events.

The company's primary product is an FDA-cleared platform that uses AI algorithms to detect abnormalities in CT scans and other imaging studies, then automatically notifies the appropriate specialist via a mobile application. The platform is used by health systems across the United States and Europe to reduce the time between imaging and specialist intervention. Viz.ai has received multiple FDA clearances for its AI algorithms across neurology, cardiology, and vascular disease indications.

Viz.ai has raised approximately $251 million in total funding, including a $100 million Series D round in 2021. The company employs between 500 and 1,000 people and has expanded its platform through partnerships with medical device manufacturers and health systems. In 2021, Viz.ai also received FDA breakthrough device designation for several of its AI-based diagnostic tools.